Cargando…

The feasibility of (18)F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with (18)F-FDG

PURPOSE: Radiolabeled arginine-glycine-aspartic acid (RGD) peptides have been developed for PET imaging of integrin avβ3 in the tumor vasculature, leading to great potential for noninvasively evaluating tumor angiogenesis and monitoring antiangiogenic treatment. The aim of this study was to investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Yanfen, Liu, Huanhuan, Liang, Sheng, Zhang, Caiyuan, Cheng, Weiwei, Hai, Wangxi, Yin, Bing, Wang, Dengbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053646/ https://www.ncbi.nlm.nih.gov/pubmed/27029065 http://dx.doi.org/10.18632/oncotarget.8402

Ejemplares similares

Quantitative Analysis and Comparison Study of [(18)F]AlF-NOTA-PRGD2, [(18)F]FPPRGD2 and [(68)Ga]Ga-NOTA-PRGD2 Using a Reference Tissue Model
por: Guo, Ning, et al.
Publicado: (2012)

Comparison of (18)F-AIF-NOTA-PRGD2 and (18)F-FDG Uptake in Lymph Node Metastasis of Differentiated Thyroid Cancer
por: Cheng, Weiwei, et al.
Publicado: (2014)

Automated GMP compliant production of [(18)F]AlF-NOTA-octreotide
por: Tshibangu, Térence, et al.
Publicado: (2020)

Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma
por: Kiesewetter, Dale O., et al.
Publicado: (2012)

Preparation, Optimisation, and In Vitro Evaluation of [(18)F]AlF-NOTA-Pamidronic Acid for Bone Imaging PET
por: Hassan, Hishar, et al.
Publicado: (2022)

Preparation and Evaluation of [(18)F]AlF-NOTA-NOC for PET Imaging of Neuroendocrine Tumors: Comparison to [(68)Ga]Ga-DOTA/NOTA-NOC
por: Dam, Johan Hygum, et al.
Publicado: (2022)

(18)F-labeled magnetic nanoparticles for monitoring anti-angiogenic therapeutic effects in breast cancer xenografts
por: Wang, Yanshu, et al.
Publicado: (2019)

Evaluation of (18)F-AlF-NOTA-octreotide for imaging neuroendocrine neoplasms: comparison with (68)Ga-DOTATATE PET/CT
por: Hou, Jiale, et al.
Publicado: (2021)

Biological Evaluation of [(18)F]AlF-NOTA-NSC-GLU as a Positron Emission Tomography Tracer for Hepatocellular Carcinoma
por: Lin, Liping, et al.
Publicado: (2021)

[(18)F] AlF‑NOTA‑FAPI‑04 PET/CT as a promising tool for imaging fibroblast activation protein in gastrointestinal system cancers: a prospective investigation of comparative analysis with (18)F-FDG
por: Yang, Liping, et al.
Publicado: (2023)

Development of a Novel PET Tracer [(18)F]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging
por: Liu, Qinghua, et al.
Publicado: (2015)

Preliminary biological evaluation of (18)F-AlF-NOTA-MAL-Cys-Annexin V as a novel apoptosis imaging agent
por: Lu, Chunxiong, et al.
Publicado: (2017)

[(18)F]AlF-NOTA-ADH-1: A new PET molecular radiotracer for imaging of N-cadherin-positive tumors
por: Liu, Zhenfeng, et al.
Publicado: (2023)

Preliminary evaluation of (18)F-AlF-NOTA-MAL-Cys(40)-Exendin-4 in rodent heart after myocardial ischemia and reperfusion
por: Pan, Xietian, et al.
Publicado: (2019)

Visualization of Activated Fibroblasts in Heart Failure with Preserved Ejection Fraction with [(18)F]AlF-NOTA-FAPI-04 PET/CT Imaging
por: Sun, Fangfang, et al.
Publicado: (2023)

Noninvasive monitoring of early antiangiogenic therapy response in human nasopharyngeal carcinoma xenograft model using MRI with RGD-conjugated ultrasmall superparamagnetic iron oxide nanoparticles
por: Cui, Yanfen, et al.
Publicado: (2016)

Prospective comparison of [(18)F]AlF-NOTA-octreotide PET/MRI to [(68)Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients
por: Boeckxstaens, Lennert, et al.
Publicado: (2023)

Evaluation of [(18)F]AlF-EMP-105 for Molecular Imaging of C-Met
por: Teh, Jin Hui, et al.
Publicado: (2023)

Preclinical comparative study of [(18)F]AlF-PSMA-11 and [(18)F]PSMA-1007 in varying PSMA expressing tumors
por: Piron, Sarah, et al.
Publicado: (2022)

Clinical application of Al(18)F-NOTA-FAPI PET/CT in diagnosis and TNM staging of pancreatic adenocarcinoma, compared to (18)F-FDG
por: Lyu, Zhehao, et al.
Publicado: (2023)

Exploring Alternative Radiolabeling Strategies for Sialic Acid-Binding Immunoglobulin-Like Lectin 9 Peptide: [(68)Ga]Ga- and [(18)F]AlF-NOTA-Siglec-9
por: Moisio, Olli, et al.
Publicado: (2018)

[(18)F]AlF-NOTA-FAPI-04 PET/CT uptake in metastatic lesions on PET/CT imaging might distinguish different pathological types of lung cancer
por: Wei, Yuchun, et al.
Publicado: (2021)

Optimized labeling of NOTA-conjugated octreotide with F-18
por: Laverman, Peter, et al.
Publicado: (2011)

(18)F-NaF and (18)F-FDG as molecular probes in the evaluation of atherosclerosis
por: McKenney-Drake, Mikaela L., et al.
Publicado: (2018)

(18)F-FLT and (18)F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results
por: Qi, Shi, et al.
Publicado: (2017)

A Dual Tracer (18)F-FCH/(18)F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model
por: Fu, Yilong, et al.
Publicado: (2016)

(18)F[AlF]-radiolabelled Peptides on the Automated Synthesis Platform: Translating the Laboratory Bench Work to Bedside
por: Hassan, Hishar, et al.
Publicado: (2019)

Automatic Production and Preliminary PET Imaging of a New Imaging Agent [(18)F]AlF-FAPT
por: Huang, JiaWen, et al.
Publicado: (2022)

(99m)Tc-3PRGD(2) SPECT Predicts the Outcome of Endostar and Cisplatin Therapy in Xenograft Animals
por: Sun, Wei, et al.
Publicado: (2019)

Pediatric Nasopharyngeal Carcinoma as Seen on 18F-FDG PET/CT
por: Muzaffar, Razi, et al.
Publicado: (2019)

Assessment of metabolic patterns and new antitumoral treatment in osteosarcoma xenograft models by [(18)F]FDG and sodium [(18)F]fluoride PET
por: Collantes, María, et al.
Publicado: (2018)

Thiol-Reactive PODS-Bearing Bifunctional Chelators for the Development of EGFR-Targeting [(18)F]AlF-Affibody Conjugates
por: Da Pieve, Chiara, et al.
Publicado: (2020)

Impact of the molar activity and PSMA expression level on [(18)F]AlF-PSMA-11 uptake in prostate cancer
por: Piron, Sarah, et al.
Publicado: (2021)

A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [(18)F]fluoride: Will [(18)F]AlF Replace (68)Ga for Metal Chelate Labeling?
por: Fersing, Cyril, et al.
Publicado: (2019)

Comparison of (18)F-NaF PET/CT and (18)F-FDG PET/CT for Detection of Skull-Base Invasion and Osseous Metastases in Nasopharyngeal Carcinoma
por: Zhang, Yin, et al.
Publicado: (2018)

Monitoring response to gefitinib in nude mouse tumor xenografts by (18) F-FDG microPET-CT: correlation between (18) F-FDG uptake and pathological response
por: Zhou, Li-Na, et al.
Publicado: (2015)

[18F]FDG and [18F]FLT positron emission tomography imaging following treatment with belinostat in human ovary cancer xenografts in mice
por: Jensen, Mette Munk, et al.
Publicado: (2013)

[18F]FLT and [18F]FDG PET for Non-invasive Treatment Monitoring of the Nicotinamide Phosphoribosyltransferase Inhibitor APO866 in Human Xenografts
por: Munk Jensen, Mette, et al.
Publicado: (2013)

A Pilot Study of Radiomics Models Combining Multi-Probe and Multi-Modality Images of (68)Ga-NOTA-PRGD2 and (18)F-FDG PET/CT for Differentiating Benign and Malignant Pulmonary Space-Occupying Lesions
por: Xie, Fei, et al.
Publicado: (2022)

Benefit of [18F]-FDG PET/CT for treatment-naïve nasopharyngeal carcinoma
por: Yang, Shan-Shan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9o5u07v79m66ss5h0smq0889oe